Peter Garcia
2014 - PDL BioPharma
In 2014, Peter Garcia earned a total compensation of $1.7M as Vice President and Chief Financial Officer at PDL BioPharma, a 171% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,000,668 |
|---|---|
| Salary | $405,600 |
| Stock Awards | $250,295 |
| Other | $58,000 |
| Total | $1,714,563 |
Garcia received $1M in non-equity incentive plan, accounting for 58% of the total pay in 2014.
Garcia also received $405.6K in salary, $250.3K in stock awards and $58K in other compensation.
Rankings
In 2014, Peter Garcia's compensation ranked 5,181st out of 13,032 executives tracked by ExecPay. In other words, Garcia earned more than 60.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,181 out of 13,032 | 60th |
Division Manufacturing | 1,848 out of 4,967 | 63rd |
Major group Chemicals And Allied Products | 615 out of 1,690 | 64th |
Industry group Drugs | 468 out of 1,369 | 66th |
Industry Biological Products, Except Diagnostic Substances | 78 out of 241 | 68th |
Source: SEC filing on April 28, 2017.
Garcia's colleagues
We found four more compensation records of executives who worked with Peter Garcia at PDL BioPharma in 2014.
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019